IL1B and cardiovascular disorder: Treatments that significantly modulated TNF‐α secretion were further explored for their effect on IL‐1β, as with TNF‐α, IL‐1β is a critical mediator in inflammation where blockade inhibits the progression of cardiovascular disease 8.